Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2021

  1. Prognostic models for mortality after cardiac surgery in patients with infective endocarditis: a systematic review and aggregation of prediction models

    Clinical Microbiology and Infection, Vol. 27, Núm. 10, pp. 1422-1430

2020

  1. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2014

  1. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study

    Journal of Cystic Fibrosis, Vol. 13, Núm. 6, pp. 716-722

2011

  1. Influence of nomenclature in the interpretation of lumbar disk contour on MR imaging: A comparison of the agreement using the combined task force and the nordic nomenclatures

    American Journal of Neuroradiology, Vol. 32, Núm. 6, pp. 1143-1148

2010

  1. Role of Endoscopy in Primary Prophylaxis for Esophageal Variceal Bleeding

    Clinics in Liver Disease, Vol. 14, Núm. 2, pp. 231-250